A Randomized, Single-blind, Placebo-controlled, Phase 1 Study to Evaluate the Safety and Pharmacokinetics of Single Doses of ABBV-382 in Healthy Adult Chinese Volunteers
Latest Information Update: 05 Jun 2025
At a glance
Most Recent Events
- 30 May 2025 Status changed from active, no longer recruiting to completed.
- 16 Jan 2025 Planned End Date changed from 14 May 2025 to 1 May 2025.
- 16 Jan 2025 Planned primary completion date changed from 14 May 2025 to 1 May 2025.